A research programme by the Access to Medicine Foundation
The foundation

Access to Medicine Foundation

The Foundation stimulates and guides pharmaceutical companies to do more to improve access to medicine. It is an independent non-profit organisation.
Our programmes

Access to Medicine Index

Ranks 20 of the world’s largest pharmaceutical companies based on their efforts to address access to medicine, including in strategy, governance, R&D and pricing. By publicly recognising the best performers, the Index spurs companies to compete to be the best.

Antimicrobial Resistance Benchmark

The first report to compare what pharmaceutical companies are doing to bring antimicrobial resistance under control. By highlighting innovative actions, it encourages more companies to seize opportunities for change.

Access to Vaccines Index

Reports what vaccine companies are doing to ensure all children can be immunised wherever they live. By uncovering what is working and where, this Index helps ensure vaccine markets also reach the poorest and most remote communities.
Type search term(s) and press enter
Often searched for
Index Ranking Vacancies 10-year analysis R&D pipelines AMR antibiotics Investors

In the media

Read how the global media covers how pharmaceutical companies respond to market trends and global health issues using the Foundation's research, and translates the complexity of access to medicine for the public.

All Access to Medicine Foundation Access to Medicine Index Antimicrobial Resistance Benchmark Access to Vaccines Index

30 Mar 2017

Novartis Looks to World’s Rich to Meet Need in Chronic Ailments

James Paton interviews the Foundations Executive Director, Jayasree. K. Iyer. His article focuses on how Novartis seeks to fill the funding gap f...

22 Mar 2017

Vaccination Scorecard

Andrew Jack from Financial Times Health, the weekly newsletter on health, features the first Access to Vaccines Index in the Chartwatch section of the...

14 Mar 2017

When it comes to needed vaccines, pharma offers a mixed bag

Ed Silverman from Stat writes about the first Access to Vaccines Index.

13 Mar 2017

Vaccine Makers Ranked on Pricing and Research

Donald Mc.Neil Jr. from The New York Times writes about the first Access to Vaccines Index and the performance of the companies in Index.

11 Mar 2017

Evaluating industry’s role in vaccine access

The Lancet covers the first Access to Vaccines Index.

08 Mar 2017

Vaccins: un engagement variable des laboratoires dans les pays du Sud

Catherine Ducruet from the French financial daily, Les Echos covers the first Access to Vaccines Index. A summary of the article – GSK et Sanofi sont...

08 Mar 2017

“We need to encourage more manufacturers to enter and stay in the (vaccines) market”

In an interview with Viveka Roychowdhury of Express Pharma, Jayasree K. Iyer, Executive Director of the Access to Medicine Foundation, discusses...

06 Mar 2017

‘Fabrikanten werken aan vaccinaties voor ebola en hiv’

The Dutch news website nu.nl covers the first Access to Vaccines Index and mentions that companies are working on vaccines for ebola and HIV.

06 Mar 2017

GSK and J&J lead in vaccines research – but pricing still an issue

Andrew McConaghie writes about the Access to Vaccines Index for PharmaPhorum. He leads with the finding that GSK and Johnson & Johnson are leading R&D...

06 Mar 2017

Vaccins tegen ebola en malaria in de maak

Karel Berkhout covers the publication of the Access to Vaccines Index 2017, in particular referring to the development of new vaccines against ebola a...

06 Mar 2017

Save the Children welcomes the Access to Vaccines Index

Save the Children welcomes the first Access to Vaccines Index as a new catalyst to stimulate action from pharmaceutical companies to improve access to...

05 Mar 2017

Hoop voor veel ernstig zieken

Writing in the NRC, Karel Berkhout covers the publication of the Access to Vaccines Index in two articles (Dutch language). In this article, he writes...

21 Jan 2017

Access to Medicine Index—what about sustainability?

David L Heymann comments about the Access to Medicine Index in the Lancet. 

20 Jan 2017

A Helping Hand

In the article, Viveka Roychowdhury refers to the performance of the companies in the 2016 Access to Medicine Index, and interviews Jayasree K. Iyer,...

14 Dec 2016

Waarom de ‘Access to medicine index’ zich ook op de thuismarkten van de farma moet richten

An article written by Lucien Hordijk, published in the NTvG (The Dutch Journal of Medicine), asks the question whether the Access to Medicine Index sh...

01 Dec 2016

Accessing Big Pharma’s Conscience

The Medicine Maker interviews Jayasree K. Iyer for their December issue. In the interview, Jayasree discusses the Access to Medicine Foundation, the A...

Got a question?

Learn more

View our detailed overview of each company’s performance in the Index, including breakdowns of their product portfolios and R&D pipelines.